John Libbey Eurotext

European Journal of Dermatology

MENU

Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia Volume 32, numéro 3, May-June 2022

Illustrations

  • Figure 1.
Auteurs
1 Department of Dermatology, Hyogo Prefectural Amagasaki General Medical Center, 2-17-77 Higashinaniwa-cho, Amagasaki, Hyogo, 660-8550, Japan
2 Department of Pathology, Hyogo Prefectural Amagasaki General Medical Center, 2-17-77 Higashinaniwa-cho, Amagasaki, Hyogo, 660-8550, Japan

A 19-year-old man with X-linked agammaglobulinemia (XLA) presented to the dermatology clinic with a four-month history of exacerbation of dermatitis and impetigo. He was diagnosed with XLA at one month of age and received immunoglobulin replacement therapy regularly. Moreover, since he was an infant, he had mild atopic dermatitis (AD), which responded to oxytetracycline hydrochloride and hydrocortisone ointment, and allergic rhinitis. His sister also had AD. However, four months before presentation, [...]